Literature DB >> 21632523

A role for XRCC2 gene polymorphisms in breast cancer risk and survival.

Wei-Yu Lin1, Nicola J Camp, Lisa A Cannon-Albright, Kristina Allen-Brady, Sabapathy Balasubramanian, Malcolm W R Reed, John L Hopper, Carmel Apicella, Graham G Giles, Melissa C Southey, Roger L Milne, Jose I Arias-Pérez, Primitiva Menéndez-Rodríguez, Javier Benítez, Magdalena Grundmann, Natalia Dubrowinskaja, Tjoung-Won Park-Simon, Thilo Dörk, Montserrat Garcia-Closas, Jonine Figueroa, Mark Sherman, Jolanta Lissowska, Douglas F Easton, Alison M Dunning, Preetha Rajaraman, Alice J Sigurdson, Michele M Doody, Martha S Linet, Paul D Pharoah, Marjanka K Schmidt, Angela Cox.   

Abstract

BACKGROUND: The XRCC2 gene is a key mediator in the homologous recombination repair of DNA double strand breaks. It is hypothesised that inherited variants in the XRCC2 gene might also affect susceptibility to, and survival from, breast cancer.
METHODS: The study genotyped 12 XRCC2 tagging single nucleotide polymorphisms (SNPs) in 1131 breast cancer cases and 1148 controls from the Sheffield Breast Cancer Study (SBCS), and examined their associations with breast cancer risk and survival by estimating ORs and HRs, and their corresponding 95% CIs. Positive findings were further investigated in 860 cases and 869 controls from the Utah Breast Cancer Study (UBCS) and jointly analysed together with available published data for breast cancer risk. The survival findings were further confirmed in studies (8074 cases) from the Breast Cancer Association Consortium (BCAC).
RESULTS: The most significant association with breast cancer risk in the SBCS dataset was the XRCC2 rs3218408 SNP (recessive model p=2.3×10(-4), minor allele frequency (MAF)=0.23). This SNP yielded an OR(rec) of 1.64 (95% CI 1.25 to 2.16) in a two-site analysis of SBCS and UBCS, and a meta-OR(rec) of 1.33 (95% CI 1.12 to 1.57) when all published data were included. This SNP may mark a rare risk haplotype carried by two in 1000 of the control population. Furthermore, the XRCC2 coding R188H SNP (rs3218536, MAF=0.08) was significantly associated with poor survival, with an increased per-allele HR of 1.58 (95% CI 1.01 to 2.49) in a multivariate analysis. This effect was still evident in a pooled meta-analysis of 8781 breast cancer patients from the BCAC (HR 1.19, 95% CI 1.05 to 1.36; p=0.01).
CONCLUSIONS: These findings suggest that XRCC2 SNPs may influence breast cancer risk and survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632523      PMCID: PMC3932658          DOI: 10.1136/jmedgenet-2011-100018

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  48 in total

Review 1.  Chromosomal stability and the DNA double-stranded break connection.

Authors:  D C van Gent; J H Hoeijmakers; R Kanaar
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

2.  Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells.

Authors:  I U De Silva; P J McHugh; P H Clingen; J A Hartley
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Pattern of sequence variation across 213 environmental response genes.

Authors:  Robert J Livingston; Andrew von Niederhausern; Anil G Jegga; Dana C Crawford; Christopher S Carlson; Mark J Rieder; Sivakumar Gowrisankar; Bruce J Aronow; Robert B Weiss; Deborah A Nickerson
Journal:  Genome Res       Date:  2004-09-13       Impact factor: 9.043

4.  Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status.

Authors:  Debbie Sprong; Hilde L Janssen; Conchita Vens; Adrian C Begg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-12-15       Impact factor: 7.038

5.  A role for XRCC4 in age at diagnosis and breast cancer risk.

Authors:  Kristina Allen-Brady; Lisa A Cannon-Albright; Susan L Neuhausen; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

6.  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.

Authors:  Antonis C Antoniou; Xianshu Wang; Zachary S Fredericksen; Lesley McGuffog; Robert Tarrell; Olga M Sinilnikova; Sue Healey; Jonathan Morrison; Christiana Kartsonaki; Timothy Lesnick; Maya Ghoussaini; Daniel Barrowdale; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Diana Eccles; D Gareth Evans; Ros Eeles; Louise Izatt; Carol Chu; Fiona Douglas; Joan Paterson; Dominique Stoppa-Lyonnet; Claude Houdayer; Sylvie Mazoyer; Sophie Giraud; Christine Lasset; Audrey Remenieras; Olivier Caron; Agnès Hardouin; Pascaline Berthet; Frans B L Hogervorst; Matti A Rookus; Agnes Jager; Ans van den Ouweland; Nicoline Hoogerbrugge; Rob B van der Luijt; Hanne Meijers-Heijboer; Encarna B Gómez García; Peter Devilee; Maaike P G Vreeswijk; Jan Lubinski; Anna Jakubowska; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Cezary Cybulski; Amanda B Spurdle; Helene Holland; David E Goldgar; Esther M John; John L Hopper; Melissa Southey; Saundra S Buys; Mary B Daly; Mary-Beth Terry; Rita K Schmutzler; Barbara Wappenschmidt; Christoph Engel; Alfons Meindl; Sabine Preisler-Adams; Norbert Arnold; Dieter Niederacher; Christian Sutter; Susan M Domchek; Katherine L Nathanson; Timothy Rebbeck; Joanne L Blum; Marion Piedmonte; Gustavo C Rodriguez; Katie Wakeley; John F Boggess; Jack Basil; Stephanie V Blank; Eitan Friedman; Bella Kaufman; Yael Laitman; Roni Milgrom; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; Tomas Kirchhoff; Joseph Vijai; Mia M Gaudet; David Altshuler; Candace Guiducci; Niklas Loman; Katja Harbst; Johanna Rantala; Hans Ehrencrona; Anne-Marie Gerdes; Mads Thomassen; Lone Sunde; Paolo Peterlongo; Siranoush Manoukian; Bernardo Bonanni; Alessandra Viel; Paolo Radice; Trinidad Caldes; Miguel de la Hoya; Christian F Singer; Anneliese Fink-Retter; Mark H Greene; Phuong L Mai; Jennifer T Loud; Lucia Guidugli; Noralane M Lindor; Thomas V O Hansen; Finn C Nielsen; Ignacio Blanco; Conxi Lazaro; Judy Garber; Susan J Ramus; Simon A Gayther; Catherine Phelan; Stephen Narod; Csilla I Szabo; Javier Benitez; Ana Osorio; Heli Nevanlinna; Tuomas Heikkinen; Maria A Caligo; Mary S Beattie; Ute Hamann; Andrew K Godwin; Marco Montagna; Cinzia Casella; Susan L Neuhausen; Beth Y Karlan; Nadine Tung; Amanda E Toland; Jeffrey Weitzel; Olofunmilayo Olopade; Jacques Simard; Penny Soucy; Wendy S Rubinstein; Adalgeir Arason; Gad Rennert; Nicholas G Martin; Grant W Montgomery; Jenny Chang-Claude; Dieter Flesch-Janys; Hiltrud Brauch; Gianluca Severi; Laura Baglietto; Angela Cox; Simon S Cross; Penelope Miron; Sue M Gerty; William Tapper; Drakoulis Yannoukakos; George Fountzilas; Peter A Fasching; Matthias W Beckmann; Isabel Dos Santos Silva; Julian Peto; Diether Lambrechts; Robert Paridaens; Thomas Rüdiger; Asta Försti; Robert Winqvist; Katri Pylkäs; Robert B Diasio; Adam M Lee; Jeanette Eckel-Passow; Celine Vachon; Fiona Blows; Kristy Driver; Alison Dunning; Paul P D Pharoah; Kenneth Offit; V Shane Pankratz; Hakon Hakonarson; Georgia Chenevix-Trench; Douglas F Easton; Fergus J Couch
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 38.330

7.  Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination.

Authors:  R D Johnson; N Liu; M Jasin
Journal:  Nature       Date:  1999-09-23       Impact factor: 49.962

8.  Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Authors:  Kelly L Bolton; Jonathan Tyrer; Honglin Song; Susan J Ramus; Maria Notaridou; Chris Jones; Tanya Sher; Aleksandra Gentry-Maharaj; Eva Wozniak; Ya-Yu Tsai; Joanne Weidhaas; Daniel Paik; David J Van Den Berg; Daniel O Stram; Celeste Leigh Pearce; Anna H Wu; Wendy Brewster; Hoda Anton-Culver; Argyrios Ziogas; Steven A Narod; Douglas A Levine; Stanley B Kaye; Robert Brown; Jim Paul; James Flanagan; Weiva Sieh; Valerie McGuire; Alice S Whittemore; Ian Campbell; Martin E Gore; Jolanta Lissowska; Hanna P Yang; Krzysztof Medrek; Jacek Gronwald; Jan Lubinski; Anna Jakubowska; Nhu D Le; Linda S Cook; Linda E Kelemen; Angela Brooks-Wilson; Angela Brook-Wilson; Leon F A G Massuger; Lambertus A Kiemeney; Katja K H Aben; Anne M van Altena; Richard Houlston; Ian Tomlinson; Rachel T Palmieri; Patricia G Moorman; Joellen Schildkraut; Edwin S Iversen; Catherine Phelan; Robert A Vierkant; Julie M Cunningham; Ellen L Goode; Brooke L Fridley; Susan Kruger-Kjaer; Jan Blaeker; Estrid Hogdall; Claus Hogdall; Jenny Gross; Beth Y Karlan; Roberta B Ness; Robert P Edwards; Kunle Odunsi; Kirsten B Moyisch; Julie A Baker; Francesmary Modugno; Tuomas Heikkinenen; Ralf Butzow; Heli Nevanlinna; Arto Leminen; Natalia Bogdanova; Natalia Antonenkova; Thilo Doerk; Peter Hillemanns; Matthias Dürst; Ingo Runnebaum; Pamela J Thompson; Michael E Carney; Marc T Goodman; Galina Lurie; Shan Wang-Gohrke; Rebecca Hein; Jenny Chang-Claude; Mary Anne Rossing; Kara L Cushing-Haugen; Jennifer Doherty; Chu Chen; Thorunn Rafnar; Soren Besenbacher; Patrick Sulem; Kari Stefansson; Michael J Birrer; Kathryn L Terry; Dena Hernandez; Daniel W Cramer; Ignace Vergote; Frederic Amant; Diether Lambrechts; Evelyn Despierre; Peter A Fasching; Matthias W Beckmann; Falk C Thiel; Arif B Ekici; Xiaoqing Chen; Sharon E Johnatty; Penelope M Webb; Jonathan Beesley; Stephen Chanock; Montserrat Garcia-Closas; Tom Sellers; Douglas F Easton; Andrew Berchuck; Georgia Chenevix-Trench; Paul D P Pharoah; Simon A Gayther
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 41.307

9.  PedGenie: an analysis approach for genetic association testing in extended pedigrees and genealogies of arbitrary size.

Authors:  Kristina Allen-Brady; Jathine Wong; Nicola J Camp
Journal:  BMC Bioinformatics       Date:  2006-04-18       Impact factor: 3.169

10.  PedGenie: meta genetic association testing in mixed family and case-control designs.

Authors:  Karen Curtin; Jathine Wong; Kristina Allen-Brady; Nicola J Camp
Journal:  BMC Bioinformatics       Date:  2007-11-15       Impact factor: 3.169

View more
  30 in total

1.  MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.

Authors:  Jingjing Cao; Chenglin Luo; Rui Peng; Qiaoyun Guo; Kaijuan Wang; Peng Wang; Hua Ye; Chunhua Song
Journal:  Tumour Biol       Date:  2016-10-10

2.  The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.

Authors:  Shujing Shi; Lingyan Qin; Mengqiu Tian; Mao Xie; Xiaoxue Li; Chenglin Qi; Xiang Yi
Journal:  Tumour Biol       Date:  2014-03-06

3.  XRCC2 gene polymorphisms and its protein are associated with colorectal cancer susceptibility in Chinese Han population.

Authors:  Xia-Bin Li; Hua Luo; Juan Huang; Jie-Dong Zhang; Zi-Xi Yang; Xing-Wang Sun
Journal:  Med Oncol       Date:  2014-10-11       Impact factor: 3.064

4.  Novel genetic variants of SYK and ITGA1 related lymphangiogenesis signaling pathway predict non-small cell lung cancer survival.

Authors:  Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Lijuan Lin; David C Christiani; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

5.  Rare mutations in XRCC2 increase the risk of breast cancer.

Authors:  D J Park; F Lesueur; T Nguyen-Dumont; M Pertesi; F Odefrey; F Hammet; S L Neuhausen; E M John; I L Andrulis; M B Terry; M Daly; S Buys; F Le Calvez-Kelm; A Lonie; B J Pope; H Tsimiklis; C Voegele; F M Hilbers; N Hoogerbrugge; A Barroso; A Osorio; G G Giles; P Devilee; J Benitez; J L Hopper; S V Tavtigian; D E Goldgar; M C Southey
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

6.  An association between the -41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer.

Authors:  Magdalena M Michalska; Dariusz Samulak; Beata Smolarz
Journal:  Med Oncol       Date:  2014-10-30       Impact factor: 3.064

Review 7.  From yeast to mammals: recent advances in genetic control of homologous recombination.

Authors:  Yoav Karpenshif; Kara A Bernstein
Journal:  DNA Repair (Amst)       Date:  2012-08-11

8.  Linking clinical research data to population databases.

Authors:  Linda S Edelman; Jia-Wen Guo; Alison Fraser; Susan L Beck
Journal:  Nurs Res       Date:  2013 Nov-Dec       Impact factor: 2.381

9.  Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study.

Authors:  G Gowtham Kumar; Solomon Franklin Durairaj Paul; Jovita Martin; M Manickavasagam; Shirley Sundersingh; Nalini Ganesan; R Ramya; G Usha Rani; Francis Andrea Mary
Journal:  Mol Biol Rep       Date:  2021-06-07       Impact factor: 2.316

10.  Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.

Authors:  Zhendong Liu; Wang Zhang; Xingbo Cheng; Hongbo Wang; Lu Bian; Jialin Wang; Zhibin Han; Yanbiao Wang; Xiaoyu Lian; Binfeng Liu; Zhishuai Ren; Bo Zhang; Zhenfeng Jiang; Zhiguo Lin; Yanzheng Gao
Journal:  Mol Med       Date:  2021-05-29       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.